Here, we report a female patient developing neuroleptic malignant syndrome following the use of a combination of clozapine and haloperidol. Subsequently, the patient presented withdrawal effects after an abrupt discontinuation of clozapine. Psychiatrists not aware of possible clozapine-withdrawal effects may misdiagnose as a part of the primary mental illness or as the initial symptoms worsening, if unrecognized.
CITATION STYLE
Cheng, M., Gu, H., Zheng, L., Wang, H., Zhong, Z., & Wen, S. (2016). Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia. Neuropsychiatric Disease and Treatment, 12, 695–697. https://doi.org/10.2147/NDT.S103687
Mendeley helps you to discover research relevant for your work.